[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Plasma Protein Therapeutics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

January 2024 | 110 pages | ID: G4895C053D9EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Plasma Protein Therapeutics market size was valued at USD 28880 million in 2023 and is forecast to a readjusted size of USD 44910 million by 2030 with a CAGR of 6.5% during review period.

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.

The Global Info Research report includes an overview of the development of the Plasma Protein Therapeutics industry chain, the market status of Hemophilia (Coagulation Factor, Immune Globulin), PID (Coagulation Factor, Immune Globulin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Plasma Protein Therapeutics.

Regionally, the report analyzes the Plasma Protein Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Plasma Protein Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Plasma Protein Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Plasma Protein Therapeutics industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Coagulation Factor, Immune Globulin).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Plasma Protein Therapeutics market.

Regional Analysis: The report involves examining the Plasma Protein Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Plasma Protein Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Plasma Protein Therapeutics:

Company Analysis: Report covers individual Plasma Protein Therapeutics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Plasma Protein Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hemophilia, PID).

Technology Analysis: Report covers specific technologies relevant to Plasma Protein Therapeutics. It assesses the current state, advancements, and potential future developments in Plasma Protein Therapeutics areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Plasma Protein Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Plasma Protein Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • Coagulation Factor
  • Immune Globulin
  • Albumin
  • Others
Market segment by Application
  • Hemophilia
  • PID
  • Others
Major players covered
  • Shire (Baxalta)
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Kamada
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Plasma Protein Therapeutics product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Plasma Protein Therapeutics, with price, sales, revenue and global market share of Plasma Protein Therapeutics from 2019 to 2024.

Chapter 3, the Plasma Protein Therapeutics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Plasma Protein Therapeutics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Plasma Protein Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Plasma Protein Therapeutics.

Chapter 14 and 15, to describe Plasma Protein Therapeutics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Plasma Protein Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Plasma Protein Therapeutics Consumption Value by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Coagulation Factor
  1.3.3 Immune Globulin
  1.3.4 Albumin
  1.3.5 Others
1.4 Market Analysis by Application
  1.4.1 Overview: Global Plasma Protein Therapeutics Consumption Value by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Hemophilia
  1.4.3 PID
  1.4.4 Others
1.5 Global Plasma Protein Therapeutics Market Size & Forecast
  1.5.1 Global Plasma Protein Therapeutics Consumption Value (2019 & 2023 & 2030)
  1.5.2 Global Plasma Protein Therapeutics Sales Quantity (2019-2030)
  1.5.3 Global Plasma Protein Therapeutics Average Price (2019-2030)

2 MANUFACTURERS PROFILES

2.1 Shire (Baxalta)
  2.1.1 Shire (Baxalta) Details
  2.1.2 Shire (Baxalta) Major Business
  2.1.3 Shire (Baxalta) Plasma Protein Therapeutics Product and Services
  2.1.4 Shire (Baxalta) Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Shire (Baxalta) Recent Developments/Updates
2.2 CSL
  2.2.1 CSL Details
  2.2.2 CSL Major Business
  2.2.3 CSL Plasma Protein Therapeutics Product and Services
  2.2.4 CSL Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 CSL Recent Developments/Updates
2.3 Grifols
  2.3.1 Grifols Details
  2.3.2 Grifols Major Business
  2.3.3 Grifols Plasma Protein Therapeutics Product and Services
  2.3.4 Grifols Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Grifols Recent Developments/Updates
2.4 Octapharma
  2.4.1 Octapharma Details
  2.4.2 Octapharma Major Business
  2.4.3 Octapharma Plasma Protein Therapeutics Product and Services
  2.4.4 Octapharma Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Octapharma Recent Developments/Updates
2.5 Kedrion
  2.5.1 Kedrion Details
  2.5.2 Kedrion Major Business
  2.5.3 Kedrion Plasma Protein Therapeutics Product and Services
  2.5.4 Kedrion Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Kedrion Recent Developments/Updates
2.6 LFB Group
  2.6.1 LFB Group Details
  2.6.2 LFB Group Major Business
  2.6.3 LFB Group Plasma Protein Therapeutics Product and Services
  2.6.4 LFB Group Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 LFB Group Recent Developments/Updates
2.7 Biotest
  2.7.1 Biotest Details
  2.7.2 Biotest Major Business
  2.7.3 Biotest Plasma Protein Therapeutics Product and Services
  2.7.4 Biotest Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Biotest Recent Developments/Updates
2.8 BPL
  2.8.1 BPL Details
  2.8.2 BPL Major Business
  2.8.3 BPL Plasma Protein Therapeutics Product and Services
  2.8.4 BPL Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 BPL Recent Developments/Updates
2.9 RAAS
  2.9.1 RAAS Details
  2.9.2 RAAS Major Business
  2.9.3 RAAS Plasma Protein Therapeutics Product and Services
  2.9.4 RAAS Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 RAAS Recent Developments/Updates
2.10 CBPO
  2.10.1 CBPO Details
  2.10.2 CBPO Major Business
  2.10.3 CBPO Plasma Protein Therapeutics Product and Services
  2.10.4 CBPO Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 CBPO Recent Developments/Updates
2.11 Hualan Bio
  2.11.1 Hualan Bio Details
  2.11.2 Hualan Bio Major Business
  2.11.3 Hualan Bio Plasma Protein Therapeutics Product and Services
  2.11.4 Hualan Bio Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.11.5 Hualan Bio Recent Developments/Updates
2.12 Kamada
  2.12.1 Kamada Details
  2.12.2 Kamada Major Business
  2.12.3 Kamada Plasma Protein Therapeutics Product and Services
  2.12.4 Kamada Plasma Protein Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.12.5 Kamada Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: PLASMA PROTEIN THERAPEUTICS BY MANUFACTURER

3.1 Global Plasma Protein Therapeutics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Plasma Protein Therapeutics Revenue by Manufacturer (2019-2024)
3.3 Global Plasma Protein Therapeutics Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
  3.4.1 Producer Shipments of Plasma Protein Therapeutics by Manufacturer Revenue ($MM) and Market Share (%): 2023
  3.4.2 Top 3 Plasma Protein Therapeutics Manufacturer Market Share in 2023
  3.4.2 Top 6 Plasma Protein Therapeutics Manufacturer Market Share in 2023
3.5 Plasma Protein Therapeutics Market: Overall Company Footprint Analysis
  3.5.1 Plasma Protein Therapeutics Market: Region Footprint
  3.5.2 Plasma Protein Therapeutics Market: Company Product Type Footprint
  3.5.3 Plasma Protein Therapeutics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Plasma Protein Therapeutics Market Size by Region
  4.1.1 Global Plasma Protein Therapeutics Sales Quantity by Region (2019-2030)
  4.1.2 Global Plasma Protein Therapeutics Consumption Value by Region (2019-2030)
  4.1.3 Global Plasma Protein Therapeutics Average Price by Region (2019-2030)
4.2 North America Plasma Protein Therapeutics Consumption Value (2019-2030)
4.3 Europe Plasma Protein Therapeutics Consumption Value (2019-2030)
4.4 Asia-Pacific Plasma Protein Therapeutics Consumption Value (2019-2030)
4.5 South America Plasma Protein Therapeutics Consumption Value (2019-2030)
4.6 Middle East and Africa Plasma Protein Therapeutics Consumption Value (2019-2030)

5 MARKET SEGMENT BY TYPE

5.1 Global Plasma Protein Therapeutics Sales Quantity by Type (2019-2030)
5.2 Global Plasma Protein Therapeutics Consumption Value by Type (2019-2030)
5.3 Global Plasma Protein Therapeutics Average Price by Type (2019-2030)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Plasma Protein Therapeutics Sales Quantity by Application (2019-2030)
6.2 Global Plasma Protein Therapeutics Consumption Value by Application (2019-2030)
6.3 Global Plasma Protein Therapeutics Average Price by Application (2019-2030)

7 NORTH AMERICA

7.1 North America Plasma Protein Therapeutics Sales Quantity by Type (2019-2030)
7.2 North America Plasma Protein Therapeutics Sales Quantity by Application (2019-2030)
7.3 North America Plasma Protein Therapeutics Market Size by Country
  7.3.1 North America Plasma Protein Therapeutics Sales Quantity by Country (2019-2030)
  7.3.2 North America Plasma Protein Therapeutics Consumption Value by Country (2019-2030)
  7.3.3 United States Market Size and Forecast (2019-2030)
  7.3.4 Canada Market Size and Forecast (2019-2030)
  7.3.5 Mexico Market Size and Forecast (2019-2030)

8 EUROPE

8.1 Europe Plasma Protein Therapeutics Sales Quantity by Type (2019-2030)
8.2 Europe Plasma Protein Therapeutics Sales Quantity by Application (2019-2030)
8.3 Europe Plasma Protein Therapeutics Market Size by Country
  8.3.1 Europe Plasma Protein Therapeutics Sales Quantity by Country (2019-2030)
  8.3.2 Europe Plasma Protein Therapeutics Consumption Value by Country (2019-2030)
  8.3.3 Germany Market Size and Forecast (2019-2030)
  8.3.4 France Market Size and Forecast (2019-2030)
  8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  8.3.6 Russia Market Size and Forecast (2019-2030)
  8.3.7 Italy Market Size and Forecast (2019-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Plasma Protein Therapeutics Market Size by Region
  9.3.1 Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Region (2019-2030)
  9.3.2 Asia-Pacific Plasma Protein Therapeutics Consumption Value by Region (2019-2030)
  9.3.3 China Market Size and Forecast (2019-2030)
  9.3.4 Japan Market Size and Forecast (2019-2030)
  9.3.5 Korea Market Size and Forecast (2019-2030)
  9.3.6 India Market Size and Forecast (2019-2030)
  9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  9.3.8 Australia Market Size and Forecast (2019-2030)

10 SOUTH AMERICA

10.1 South America Plasma Protein Therapeutics Sales Quantity by Type (2019-2030)
10.2 South America Plasma Protein Therapeutics Sales Quantity by Application (2019-2030)
10.3 South America Plasma Protein Therapeutics Market Size by Country
  10.3.1 South America Plasma Protein Therapeutics Sales Quantity by Country (2019-2030)
  10.3.2 South America Plasma Protein Therapeutics Consumption Value by Country (2019-2030)
  10.3.3 Brazil Market Size and Forecast (2019-2030)
  10.3.4 Argentina Market Size and Forecast (2019-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Plasma Protein Therapeutics Market Size by Country
  11.3.1 Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Country (2019-2030)
  11.3.2 Middle East & Africa Plasma Protein Therapeutics Consumption Value by Country (2019-2030)
  11.3.3 Turkey Market Size and Forecast (2019-2030)
  11.3.4 Egypt Market Size and Forecast (2019-2030)
  11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  11.3.6 South Africa Market Size and Forecast (2019-2030)

12 MARKET DYNAMICS

12.1 Plasma Protein Therapeutics Market Drivers
12.2 Plasma Protein Therapeutics Market Restraints
12.3 Plasma Protein Therapeutics Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Plasma Protein Therapeutics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plasma Protein Therapeutics
13.3 Plasma Protein Therapeutics Production Process
13.4 Plasma Protein Therapeutics Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Plasma Protein Therapeutics Typical Distributors
14.3 Plasma Protein Therapeutics Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Plasma Protein Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Plasma Protein Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Shire (Baxalta) Basic Information, Manufacturing Base and Competitors
Table 4. Shire (Baxalta) Major Business
Table 5. Shire (Baxalta) Plasma Protein Therapeutics Product and Services
Table 6. Shire (Baxalta) Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Shire (Baxalta) Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Plasma Protein Therapeutics Product and Services
Table 11. CSL Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSL Recent Developments/Updates
Table 13. Grifols Basic Information, Manufacturing Base and Competitors
Table 14. Grifols Major Business
Table 15. Grifols Plasma Protein Therapeutics Product and Services
Table 16. Grifols Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Grifols Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Plasma Protein Therapeutics Product and Services
Table 21. Octapharma Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Octapharma Recent Developments/Updates
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Plasma Protein Therapeutics Product and Services
Table 26. Kedrion Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Kedrion Recent Developments/Updates
Table 28. LFB Group Basic Information, Manufacturing Base and Competitors
Table 29. LFB Group Major Business
Table 30. LFB Group Plasma Protein Therapeutics Product and Services
Table 31. LFB Group Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. LFB Group Recent Developments/Updates
Table 33. Biotest Basic Information, Manufacturing Base and Competitors
Table 34. Biotest Major Business
Table 35. Biotest Plasma Protein Therapeutics Product and Services
Table 36. Biotest Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biotest Recent Developments/Updates
Table 38. BPL Basic Information, Manufacturing Base and Competitors
Table 39. BPL Major Business
Table 40. BPL Plasma Protein Therapeutics Product and Services
Table 41. BPL Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. BPL Recent Developments/Updates
Table 43. RAAS Basic Information, Manufacturing Base and Competitors
Table 44. RAAS Major Business
Table 45. RAAS Plasma Protein Therapeutics Product and Services
Table 46. RAAS Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. RAAS Recent Developments/Updates
Table 48. CBPO Basic Information, Manufacturing Base and Competitors
Table 49. CBPO Major Business
Table 50. CBPO Plasma Protein Therapeutics Product and Services
Table 51. CBPO Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. CBPO Recent Developments/Updates
Table 53. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Bio Major Business
Table 55. Hualan Bio Plasma Protein Therapeutics Product and Services
Table 56. Hualan Bio Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hualan Bio Recent Developments/Updates
Table 58. Kamada Basic Information, Manufacturing Base and Competitors
Table 59. Kamada Major Business
Table 60. Kamada Plasma Protein Therapeutics Product and Services
Table 61. Kamada Plasma Protein Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Kamada Recent Developments/Updates
Table 63. Global Plasma Protein Therapeutics Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 64. Global Plasma Protein Therapeutics Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Plasma Protein Therapeutics Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 66. Market Position of Manufacturers in Plasma Protein Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Plasma Protein Therapeutics Production Site of Key Manufacturer
Table 68. Plasma Protein Therapeutics Market: Company Product Type Footprint
Table 69. Plasma Protein Therapeutics Market: Company Product Application Footprint
Table 70. Plasma Protein Therapeutics New Market Entrants and Barriers to Market Entry
Table 71. Plasma Protein Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Plasma Protein Therapeutics Sales Quantity by Region (2019-2024) & (K Units)
Table 73. Global Plasma Protein Therapeutics Sales Quantity by Region (2025-2030) & (K Units)
Table 74. Global Plasma Protein Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Plasma Protein Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Plasma Protein Therapeutics Average Price by Region (2019-2024) & (USD/Unit)
Table 77. Global Plasma Protein Therapeutics Average Price by Region (2025-2030) & (USD/Unit)
Table 78. Global Plasma Protein Therapeutics Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Global Plasma Protein Therapeutics Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Global Plasma Protein Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Plasma Protein Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Plasma Protein Therapeutics Average Price by Type (2019-2024) & (USD/Unit)
Table 83. Global Plasma Protein Therapeutics Average Price by Type (2025-2030) & (USD/Unit)
Table 84. Global Plasma Protein Therapeutics Sales Quantity by Application (2019-2024) & (K Units)
Table 85. Global Plasma Protein Therapeutics Sales Quantity by Application (2025-2030) & (K Units)
Table 86. Global Plasma Protein Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Plasma Protein Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Plasma Protein Therapeutics Average Price by Application (2019-2024) & (USD/Unit)
Table 89. Global Plasma Protein Therapeutics Average Price by Application (2025-2030) & (USD/Unit)
Table 90. North America Plasma Protein Therapeutics Sales Quantity by Type (2019-2024) & (K Units)
Table 91. North America Plasma Protein Therapeutics Sales Quantity by Type (2025-2030) & (K Units)
Table 92. North America Plasma Protein Therapeutics Sales Quantity by Application (2019-2024) & (K Units)
Table 93. North America Plasma Protein Therapeutics Sales Quantity by Application (2025-2030) & (K Units)
Table 94. North America Plasma Protein Therapeutics Sales Quantity by Country (2019-2024) & (K Units)
Table 95. North America Plasma Protein Therapeutics Sales Quantity by Country (2025-2030) & (K Units)
Table 96. North America Plasma Protein Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Plasma Protein Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Plasma Protein Therapeutics Sales Quantity by Type (2019-2024) & (K Units)
Table 99. Europe Plasma Protein Therapeutics Sales Quantity by Type (2025-2030) & (K Units)
Table 100. Europe Plasma Protein Therapeutics Sales Quantity by Application (2019-2024) & (K Units)
Table 101. Europe Plasma Protein Therapeutics Sales Quantity by Application (2025-2030) & (K Units)
Table 102. Europe Plasma Protein Therapeutics Sales Quantity by Country (2019-2024) & (K Units)
Table 103. Europe Plasma Protein Therapeutics Sales Quantity by Country (2025-2030) & (K Units)
Table 104. Europe Plasma Protein Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Plasma Protein Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Type (2019-2024) & (K Units)
Table 107. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Type (2025-2030) & (K Units)
Table 108. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Application (2019-2024) & (K Units)
Table 109. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Application (2025-2030) & (K Units)
Table 110. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Region (2019-2024) & (K Units)
Table 111. Asia-Pacific Plasma Protein Therapeutics Sales Quantity by Region (2025-2030) & (K Units)
Table 112. Asia-Pacific Plasma Protein Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Plasma Protein Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Plasma Protein Therapeutics Sales Quantity by Type (2019-2024) & (K Units)
Table 115. South America Plasma Protein Therapeutics Sales Quantity by Type (2025-2030) & (K Units)
Table 116. South America Plasma Protein Therapeutics Sales Quantity by Application (2019-2024) & (K Units)
Table 117. South America Plasma Protein Therapeutics Sales Quantity by Application (2025-2030) & (K Units)
Table 118. South America Plasma Protein Therapeutics Sales Quantity by Country (2019-2024) & (K Units)
Table 119. South America Plasma Protein Therapeutics Sales Quantity by Country (2025-2030) & (K Units)
Table 120. South America Plasma Protein Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Plasma Protein Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Type (2019-2024) & (K Units)
Table 123. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Type (2025-2030) & (K Units)
Table 124. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Region (2019-2024) & (K Units)
Table 127. Middle East & Africa Plasma Protein Therapeutics Sales Quantity by Region (2025-2030) & (K Units)
Table 128. Middle East & Africa Plasma Protein Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Plasma Protein Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Plasma Protein Therapeutics Raw Material
Table 131. Key Manufacturers of Plasma Protein Therapeutics Raw Materials
Table 132. Plasma Protein Therapeutics Typical Distributors
Table 133. Plasma Protein Therapeutics Typical Customers

LIST OF FIGURES

Figure 1. Plasma Protein Therapeutics Picture
Figure 2. Global Plasma Protein Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Plasma Protein Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Coagulation Factor Examples
Figure 5. Immune Globulin Examples
Figure 6. Albumin Examples
Figure 7. Others Examples
Figure 8. Global Plasma Protein Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Plasma Protein Therapeutics Consumption Value Market Share by Application in 2023
Figure 10. Hemophilia Examples
Figure 11. PID Examples
Figure 12. Others Examples
Figure 13. Global Plasma Protein Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Plasma Protein Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Plasma Protein Therapeutics Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Plasma Protein Therapeutics Average Price (2019-2030) & (USD/Unit)
Figure 17. Global Plasma Protein Therapeutics Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Plasma Protein Therapeutics Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Plasma Protein Therapeutics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Plasma Protein Therapeutics Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Plasma Protein Therapeutics Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Plasma Protein Therapeutics Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Plasma Protein Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Plasma Protein Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Plasma Protein Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Plasma Protein Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Plasma Protein Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Plasma Protein Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Plasma Protein Therapeutics Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Plasma Protein Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Plasma Protein Therapeutics Average Price by Type (2019-2030) & (USD/Unit)
Figure 32. Global Plasma Protein Therapeutics Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Plasma Protein Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Plasma Protein Therapeutics Average Price by Application (2019-2030) & (USD/Unit)
Figure 35. North America Plasma Protein Therapeutics Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Plasma Protein Therapeutics Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Plasma Protein Therapeutics Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Plasma Protein Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Plasma Protein Therapeutics Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Plasma Protein Therapeutics Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Plasma Protein Therapeutics Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Plasma Protein Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Plasma Protein Therapeutics Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Plasma Protein Therapeutics Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Plasma Protein Therapeutics Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Plasma Protein Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 55. China Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Plasma Protein Therapeutics Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Plasma Protein Therapeutics Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Plasma Protein Therapeutics Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Plasma Protein Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Plasma Protein Therapeutics Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Plasma Protein Therapeutics Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Plasma Protein Therapeutics Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Plasma Protein Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Plasma Protein Therapeutics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Plasma Protein Therapeutics Market Drivers
Figure 76. Plasma Protein Therapeutics Market Restraints
Figure 77. Plasma Protein Therapeutics Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics in 2023
Figure 80. Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure 81. Plasma Protein Therapeutics Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


More Publications